There’s hope for an early-detection test that could improve survival for people with a deadly cancer linked to asbestos exposure, researchers report.High blood levels of a protein called osteopontin are linked to the development of pleural mesothelioma, an asbestos-related cancer that invades the chest cavity and the lining of the lungs, say researchers reporting in the Oct. 13 issue of the New England Journal of Medicine.
